BioHealth News Archive

AstraZeneca Aims for 30 Million U.K. Vaccine Doses by September

AstraZeneca Aims for 30 Million U.K. Vaccine Doses by September

AstraZeneca Plc will make as many as 30 million doses of coronavirus vaccine available to the U.K. by September and has committed to delivering…

Read More
Creatv’s LifeTracDxTM Blood Test for Early Detection of Aggressive Prostate Cancer

Creatv’s LifeTracDxTM Blood Test for Early Detection of Aggressive Prostate Cancer

ROCKVILLE, MD – May 19, 2020 Creatv MicroTech (Creatv), a cancer screening and diagnostic company with headquarters in Rockville, Maryland, is announcing a collaboration…

Read More
60 Projects Funded by CARB-X so far…..

60 Projects Funded by CARB-X so far…..

Since 2016, CARB-X has been funding and supporting the early development of innovative vaccines, rapid diagnostics, antibiotics and other life-saving therapeutics to address drug-resistant…

Read More
Emmes Ranked as a Top Biosciences Employer in Greater Washington

Emmes Ranked as a Top Biosciences Employer in Greater Washington

ROCKVILLE, Md., May 18, 2020 - Emmes today announced that it was ranked as the seventh largest biosciences employer in the greater Washington area. The…

Read More
Local Biotech Firms Say They Have Thousands Of Unused Coronavirus Tests | WAMU

Local Biotech Firms Say They Have Thousands Of Unused Coronavirus Tests | WAMU

When infectious disease expert Crystal Icenhour began offering COVID-19 testing last month at her Aperiomics commercial laboratory in Sterling, Va., she expected a flood…

Read More
USM to resume ‘some’ in-person learning on campuses this fall, chancellor says – Washington Business Journal

USM to resume ‘some’ in-person learning on campuses this fall, chancellor says – Washington Business Journal

University System of Maryland Chancellor Jay Perman said the system's colleges are "planning to resume at least some in-person teaching and learning" in the…

Read More
Critically Ill COVID-19 Patients Recover Following Heart Cell Therapy

Critically Ill COVID-19 Patients Recover Following Heart Cell Therapy

Researchers at Cedars-Sinai Medical Center are planning a randomized, controlled trial to evaluate a form of allogeneic cell therapy for COVID-19, after four out…

Read More
BioBuzz: Rockville, Maryland’s Sanaria at Center of an Unlikely Global Health Success Story – BioHealth Capital Region

BioBuzz: Rockville, Maryland’s Sanaria at Center of an Unlikely Global Health Success Story – BioHealth Capital Region

In 2009, a remarkable partnership started with an unsolicited email and a “cold call.” Ten years later, Rockville, Maryland’s Sanaria and the Bioko Island…

Read More
Financing Trends for Q1 2020

Financing Trends for Q1 2020

The COVID-19 pandemic has caused— and will continue to cause—much uncertainty in the worldwide financial markets. We expect to see substantial declines in the…

Read More
BIO – News Update (May 14, 2020)

BIO – News Update (May 14, 2020)

We are living and working through a period in human history when scientific leadership and knowledge are crucial for our nation, our organization and…

Read More
Maryland’s Immunomic Therapeutics Exceeds Fundraising Goal, Envisions Future IPO · BioBuzz

Maryland’s Immunomic Therapeutics Exceeds Fundraising Goal, Envisions Future IPO · BioBuzz

Immunomic Therapeutics Incorporated (ITI), located in Rockville, Maryland recently announced it had closed on $61.3M in financing, exceeding its initial fundraising projections by over…

Read More
Net Health Acquires Tissue Analytics

Net Health Acquires Tissue Analytics

PITTSBURGH, May 14, 2020 /PRNewswire/ -- Net Health, a premier provider of cloud-based Electronic Health Record (EHR) software for specialized care settings, today announced…

Read More
Biotech’s new top lobbyist is a social justice advocate.

Biotech’s new top lobbyist is a social justice advocate.

WASHINGTON — Michelle McMurry-Heath doesn’t talk about biotech the way her peers do. Where other executives and experts might bring up “access,” and “reimbursement,”…

Read More
It’s Moncef Slaoui. Trump administration settles on ex-GSK vaccines chief as Covid-19 R&D czar — reports – Endpoints News

It’s Moncef Slaoui. Trump administration settles on ex-GSK vaccines chief as Covid-19 R&D czar — reports – Endpoints News

The Trump administration has chosen their drug and vaccine development czar to head up the R&D side of the Covid-19 attack plan, but it’s…

Read More
Center for Innovative Technology campus sells for $47.35M | Virginia Business

Center for Innovative Technology campus sells for $47.35M | Virginia Business

The Center for Innovative Technology (CIT) office building complex in Herndon has sold for $47.35 million, Gov. Ralph Northam announced Thursday.  The Virginia Department…

Read More